Methods of treating disease with random copolymers

Details for Australian Patent Application No. 2005251686 (hide)

Owner Peptimmune, Inc.

Inventors Bonnin, Dustan; Yu, Bei; Baldwin, Sam; Zhang, Jianxin; Rasmussen, James; Zanelli, Eric; Johnson, Keith

Agent Shelston IP

Pub. Number AU-B-2005251686

PCT Pub. Number WO2005/120542

Priority 60/663,333 18.03.05 US; 60/569,292 07.05.04 US

Filing date 9 May 2005

Wipo publication date 22 December 2005

Acceptance publication date 8 September 2011

International Classifications

A61K 38/02 (2006.01) Medicinal preparations containing peptides - Peptides of undefined number of amino acids

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/120542 Priority application(s): WO2005/120542

8 September 2011 Application Accepted

  Published as AU-B-2005251686

19 January 2012 Standard Patent Sealed

2 February 2012 Assignment Registered

  Peptimmune, Inc. The patent has been assigned to Peptimmune Acquisition, LLC

5 April 2012 Assignment Registered

  Peptimmune Acquisition, LLC The patent has been assigned to ARES Trading S.A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251687-Nutritional formulations

2005251678-Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity